e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP
Bonsignore M. R., Parati G., Insalaco G., Castiglioni P., Marrone O., Romano S., Salvaggio A., Mancia G., Bonsignore G., Di Rienzo M.
Source:
Eur Respir J 2006; 27: 128-135
Journal Issue:
January
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bonsignore M. R., Parati G., Insalaco G., Castiglioni P., Marrone O., Romano S., Salvaggio A., Mancia G., Bonsignore G., Di Rienzo M.. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J 2006; 27: 128-135
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Blood pressure responsiveness to obstructive events during sleep after chronic CPAP
Source: Eur Respir J 2003; 21: 509-514
Year: 2003
CPAP and measures of cardiovascular risk in males with OSAS
Source: Eur Respir J 2008; 32: 1488-1496
Year: 2008
Management of hypertension in obstructive sleep apnoea: predicting blood pressure reduction under continuous positive airway pressure
Source: Eur Respir J, 50 (4) 1701822; 10.1183/13993003.01822-2017
Year: 2017
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients
Source: Eur Respir J 2006; 27: 1229-1235
Year: 2006
Obstructive sleep apnea syndrome and left ventricular diastolic function: effects of nasal continuous positive airway pressure (CPAP)
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients
Source: Eur Respir J 2004; 23: 255-262
Year: 2004
Ventilatory support and pharmacological treatment of patients with central apnoea or hypoventilation during sleep
Source: Eur Respir Rev 2007; 16: 115-124
Year: 2007
Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex
Source: Eur Respir J 2003; 21: 241-247
Year: 2003
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Role of positive airway pressure (CPAP/BOPAP) in patients with combined heart failure and sleep apnoea
Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines
Year: 2019
Residual sleep-disordered breathing during autotitrating continuous positive airway pressure therapy
Source: Eur Respir J 2012; 39: 1391-1397
Year: 2012
Differential blood pressure response to continuous positive airway pressure treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnoea
Source: Eur Respir J, 54 (1) 1900098; 10.1183/13993003.00098-2019
Year: 2019
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Sleep apnea in patients with heart failure effectiveness of continuous positive airway pressure
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008
Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
Source: Eur Respir J 2005; 26: Suppl. 49, 38s
Year: 2005
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
Proportional positive airway pressure: a new concept to treat obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 467-473
Year: 2001
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors
Source: Eur Respir J, 54 (1) 1901219; 10.1183/13993003.01219-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept